UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000015803
Receipt No. R000018387
Scientific Title Research on musical hallucination with hearing difficulty and cerebrovascular disorder
Date of disclosure of the study information 2014/12/08
Last modified on 2020/06/25 (Ver. 5)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Research on musical hallucination with hearing difficulty and cerebrovascular disorder
Acronym Research on musical hallucination with hearing difficulty and cerebrovascular disorder
Scientific Title Research on musical hallucination with hearing difficulty and cerebrovascular disorder
Scientific Title:Acronym Research on musical hallucination with hearing difficulty and cerebrovascular disorder
Region
Japan

Condition
Condition Organic hallucinosis
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To identify antiepleptics effects of musical hallucination and the responsible brain region of the symptom.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Identification of responsible brain region of musical hallucination.
Key secondary outcomes 1)The degree of auditory hallucination(Auditory Hallucination Rating Scale)
2) The Relationship between musical hallucination and dominant hemisphere.(Chapman and Chapman handedness test, Edinburgh inventory, f-MRI)

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine Gene
Interventions/Control_1 To administer antiepileptics
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1) Musical hallucination
2) Hearing difficulty
3) Cerebrovascular disorder
Key exclusion criteria Severe mental illness and dementia
Target sample size 5

Research contact person
Name of lead principal investigator
1st name Hitoshi
Middle name
Last name Sakimoto
Organization Kagoshima University Graduate School of Medical and Dental Sciences
Division name Department of Psychiatry
Zip code 890-8520
Address 35-1 8-chome, Sakuragaoka, kagoshimashi, kagoshima, 890-8520, Japan
TEL 099-275-5346
Email 02181984@m2.kufm.kagoshima-u.ac.jp

Public contact
Name of contact person
1st name Hitoshi
Middle name
Last name Sakimoto
Organization Kagoshima University Graduate School of Medical and Dental Sciences
Division name Department of Psychiatry
Zip code 890-8520
Address 35-1 8-chome, Sakuragaoka, kagoshimashi, kagoshima, 890-8520, Japan
TEL 099-275-5346
Homepage URL
Email 02181984@m2.kufm.kagoshima-u.ac.jp

Sponsor
Institute Kagoshima University Graduate School of Medical and Dental Sciences Department of Psychiatry
Institute
Department

Funding Source
Organization none
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of Kagoshima University Hospital
Address -1 8-chome, Sakuragaoka, kagoshimashi, kagoshima, 890-8520, Japan
Tel 099-275-6692
Email kufsyomu@kuas.kagoshima-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 12 Month 08 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2014 Year 12 Month 01 Day
Date of IRB
2013 Year 09 Month 13 Day
Anticipated trial start date
2014 Year 12 Month 01 Day
Last follow-up date
2021 Year 01 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2014 Year 12 Month 01 Day
Last modified on
2020 Year 06 Month 25 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018387